Organon Reports Results for the First Quarter Ended March 31, 2022
Go back to Organon Reports Results for the First Quarter Ended March 31, 2022| Merck & Co. (NYSE: MRK) | Delayed: 113.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.87 | 52 Week High | $65.46 | |||
| Open | $113.87 | 52 Week Low | $47.97 | |||
| Day High | $113.87 | P/E | 77.46 | |||
| Day Low | $113.87 | EPS | $1.47 | |||
| Volume | 9,082 | |||||
| (NYSE: OGN) | Delayed: 13.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.43 | 52 Week High | $8.00 | |||
| Open | $13.43 | 52 Week Low | $8.00 | |||
| Day High | $13.43 | P/E | N/A | |||
| Day Low | $13.43 | EPS | $0.00 | |||
| Volume | 1,707 | |||||
